Background The aim of this study was to perform an external validation of Cleveland Clinic Foundation colorectal cancer model in a single center. Methods Relevant data of 771 patients who underwent surgery for colorectal cancer between January 1997 and November 2008 were retrospectively collected. The performance of the scoring system was evaluated by discrimination and calibration. Discrimination was evaluated by using the area under the receiver operator characteristics curve and calibration by using the Hosmer-Lemeshow goodness-of-fit test. Results Mean age was 60.8 (18-91). Forty-four percent of patients were female, and 56% were male. Overall mortality was 3.9%. Cleveland Clinic Foundation colorectal cancer model showed good discrimination but poor calibration. Conclusion These data suggest that the Cleveland Clinic Foundation colorectal cancer model is a suitable model to be used in our center for patients with colorectal cancer but requires recalibration.
Introduction
Colorectal cancer being the fourth most common internal malignancy, and second only to lung cancer on the list of causes of cancer-related deaths, is a major healthcare problem. Besides the need for treatment of the individual patient, rational use of resources also requires objective evaluation and stratification of patients. This can be achieved by using predictive models based on logistic regression analysis [1] .
These predictive models can be used in everyday practice for preoperative counseling of patients and their carers, as a part of the process of informed consent. They can also be used to compare outcomes between multidisciplinary colorectal cancer teams and therefore are powerful tools, not only for the purposes of consent, but also for audit, research, training and revalidation [1] . Such models also provide objective data on surgical performance in specific risk groups. For this reason, results of surgical procedures must be subjected to objective assessment, with an emphasis on professional accountability for clinical outcomes. Meaningful comparisons of outcomes between, or within, hospitals may be undertaken with careful adjustment for patient and procedural risk factors. However, before making any inferences about the effectiveness or quality of care, it is essential to make proper risk adjustments [1, 2] .
Moreover, comparing the results of different centers from the point of view of surgical mortality must be based on objective parameters. Scoring systems are good tools to give patients correct data about the risk of surgical procedures. To accurately reflect standards of surgical performance, postoperative mortality must be adjusted for case mix, thus reflecting the relative risks of surgery in patients with different preoperative staging, comorbid disease and mode of presentation.
In 2004, Fazio et al. [2] developed a colorectal cancer model for assessment of operative risk for patients with colorectal cancer in the preoperative period. By multivariate analysis, they found that factors such as age, ASA score, TNM stage, mode of surgery, no cancer resection vs. resection and hematocrit level were independent risk factors affecting mortality. They internally validated the model and reported adequate discrimination and calibration [2] . The authors concluded that the model requires external validation by testing the model on further prospective series in different hospitals. The need for this is reinforced by epidemiologic data pointing to differences in the incidence and possibly in the prognosis of colorectal cancer between Western countries and Asia. But this system has not yet been validated in another center to assess the reliability of the model [2] .
The aim of this study was to externally validate the Cleveland Clinic Foundation colorectal cancer (CCF-CRC) model in a single academic center.
Materials and methods
A total of 771 consecutive patients who underwent colorectal surgery in our clinic between January 1997 and November 2008 were included in the study. The parameters necessary for evaluation of the CCF-CRC model were retrospectively collected from the patients' database and our operation records (Table 1) [2] .
The primary end point was to externally validate the CCF-CRC model in terms of predicting operative mortality, defined as death occurring within 30 days of an operative procedure, in our center. Validity of the CCF-CRC model has been evaluated by its discriminative ability and calibration.
Discrimination refers to the ability of a model to distinguish survivors from nonsurvivors [3] . This ability is measured by the area under the receiver operator characteristic (ROC) curve (AUC) to evaluate how well the model distinguished patients who experienced the event from those who did not [2] [3] [4] . The AUC represents the probability that a patient who died had a higher predicted probability of dying than a patient who survived [4] . Values ranging from 0.7 to 0.8 mean reasonable discrimination and values exceeding 0.8 represent good discrimination [2, 3] .
Calibration refers to the agreement between predicted probabilities and true probabilities. Calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test, chi-square and p statistics [4] . A small P value, suggesting there is a significant difference between observed and predicted mortality, indicates a lack of fit of the model. Statistical analysis of discrimination and calibration was performed by one of the investigators who was not involved in the data collection procedure, on an anonymously reported data file using Stata 9.0 (Stata Corporation, Texas, USA).
Results
Mean age at surgery was 60.8 years. The male-to-female ratio was 1.28. The in-hospital mortality rate, evaluated as mortality within the first 30 days, was 3.9% (30 patients). The demographic characteristics of the patients are shown in Table 2 .
Discrimination of the CCF-CRC scoring system was good, and the area under the ROC curve was 0.81 (AUC: 0.81 [%95 GS: 0.74-0.87], P \ 0.001; Fig. 1 ). The significant cutoff value for predicting mortality was 2. More than 55.05% of patients had a score \2. Among these patients, only 5 deaths occurred. A score over 2 increased the mortality risk 15.6-fold (%95 GS: 4.7-52.4). The CCF-CRC scoring system showed poor calibration. Hosmer-Lemeshow goodness-of-fit v 2 was 23.26, and P value was 0.003, indications of a significant difference between observed and predicted mortality and poor calibration.
Discussion
The postoperative mortality rate is the most commonly used parameter to determine the quality of care. However, for this measurement to be truly objective it must be adjusted for patient-related risk factors (case mix), because direct comparison of mortality rates may not account for the difference between populations, physiological variations of the patients and type and severity of surgery in different centers [5] . For this reason, many scoring systems were developed in the last two decades, to evaluate surgical performance in general surgery.
Two of these systems are POSSUM and P-POSSUM [5, 6] . These systems have been used for predicting mortality in all subgroups of general surgery. The accuracy of these models when applied to colorectal surgery patients was validated by Tekkis et.al. [7] , who found that there is a lack of calibration at the extremes of ages and in cases of emergency surgery.
A Colorectal Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (CR-POSSUM) system was later developed [8] . It demonstrated better accuracy in predicting mortality in colorectal surgery patients when internally validated, but the patients evaluated underwent surgery for both malignant and benign disease. Tekkis et al. [8] emphasized that external validation of the system must be performed in hospitals other than that in which the model was developed.
Not long afterward, the CR-POSSUM system was externally validated in 304 patients and showed a good fit with the data (P 0.795). It was proposed that this system be modified by the addition of albumin as a parameter [9] .
Ertan and coworkers evaluated the performance of commonly used critical care logistic regression models in patients undergoing emergency surgery colorectal surgery and found that the predicted mortality value of Mortality Probability Model II at admission performed best [4] .
Finally, Fazio et al. [2] developed the CCF-CRC model for assessment of operative risk in colorectal cancer surgery. In this model, they made adjustments for age, ASA grade, TNM stage, mode of presentation, cancer resection and hematocrit level, which are well-established, independent, prognostic factors in colorectal surgery. This model was developed in a high volume center from databases of 5,034 patients. In the same study, the model was internally validated and showed good calibration and discrimination [2] . Once again, emphasis was placed on the need for external validation and possible recalibration of Fig. 1 The figure shows the performance of CCF-CRC model according to ROC analysis (note that AUC: 0.81, which means good discriminative ability) the model if it was used in centers with higher mortality rates or centers with a lower volume of patients [2, 10] . It was also recommended that it should not be used to measure patient outcome and surgical competency until it was validated in a multicenter prospective study [10] . Despite its reliable discriminative power, the CCF-CRC model showed poor calibration in our study. Since calibration is a measure of agreement between the predicted and true mortality rates within percentiles, lack of calibration may point to problems in the generalization of the model for use in all subgroups. This may be due to differences in preoperative and postoperative care, admission and discharge policies, and the experience of surgical teams in different centers. In order to overcome this problem, each center can perform recalibration of the original predictive model in a sufficiently large population of patients. This, in turn, reduces the feasibility of the model [7] .
To our knowledge, this is the first study to externally validate the CCF-CRC model in a single center. As a result, we have demonstrated that it has good discrimination but poor calibration.
In conclusion, populations in different countries may have different risk factors that cause adverse outcomes, and these risk factors must be determined individually, in different centers, in a prospective study. If not, the newly developed scoring models must be validated, for use in another center. The CCF-CRC model is a suitable for use in our center in patients with colorectal cancer, but requires recalibration.
